Dentons advises Invenio Partners on the sale of a majority stake in Haelan healthcare to Provectus Capital Partners

Global law firm Dentons has advised private equity firm INVENIO Partners on the sale of a majority stake in the integrated healthcare provider Haelan to Provectus Capital Partners. The deal, which was signed in July 2026, is subject to customary regulatory approvals. Upon completion, INVENIO Partners will retain a significant minority stake.

Haelan is one of Bulgaria's leading private healthcare platforms. Since INVENIO Partners' investment, the business has grown into a diversified healthcare group combining Bulgaria's largest outpatient network with complementary hospital care.

Provectus Capital Partners is an independent private equity firm focused on investments in Southeast Europe. Together with INVENIO Partners, it will work alongside the management team to support Haelan's continued expansion, strengthen its clinical capabilities and broaden access to high-quality healthcare services across Bulgaria.

Budapest partner Kamran Pirani led Dentons' legal team, with support from lawyers across the firm's Budapest and Prague offices, including Prague associate Abbey Varns and counsel Lukas Poulik, and Budapest counsel Sebastian Ishiguro.

Kamran Pirani, partner at Dentons, commented: "We are delighted to have advised INVENIO Partners on this important milestone in Haelan's development. The transaction brings together two experienced regional investors to support the platform's next stage of growth and reflects continued private equity interest in the healthcare sector across Southeast Europe."

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com